手机验证
At or Below -20°C
包装说明
CleanCap® Reagent (3' OMe) AG
大量
欣博盛生物科技有限公司
10 umol
CleanCap AG (3'OMe)用于mRNA的共转录,m7(3'OMeG)(5')ppp(5')(2'OMeA)pG
产品描述:
CleanCap®AG (3' OMe)是TriLink公司的专有的共转录加帽试剂,用于5 '帽端mRNA转录,形成Cap 1结构。CleanCap的加帽效率高达98%。Trilink N-7413TrilinkCleanCap®Reagent AG共转录产品的cap1mRNA要比 mCAP和ARCA加帽产生的cap0 mRNA活性更好。
产品信息:
产品货号 | N-7413 |
纯度 | ≥95% by AX-HPLC |
消光系数 | 30,539 Lmol-1cm-1 at 255 nm |
分子式 | C33H45N15O24P4 (游离酸) |
分子质量 | 1159.6 |
盐形式 | Na+ |
浓度 | 100 mM |
溶液组分 | 水 |
推荐的储存温度 | -20°C 或者以下 |
其他名称 | CleanCap® Reagent AG(3' OMe) for co-transcriptional capping of mRNA, m7(3'OMeG)(5’)ppp(5')(2'OMeA)pG |
应用 | CRISPR, In vitro Transcription, Recombinases, TALENS, Transposases, Vaccine Development, Zinc Finger Nucleases |
主链 | 5'-5'-三磷酸 |
碱基类似物 | 腺苷酸,鸟苷酸 |
核苷酸种类 | 帽类似物 |
产品规格如下:
供应商 | 产品编号 | 产品名称 | 规格 |
TriLink | N-7413-1 | CleanCap Reagent AG(3'OMe), 1 umole | 1 umol |
TriLink | N-7413-5 | CleanCap Reagent AG(3'OMe), 5 umole | 5 umol |
TriLink | N-7413-10 | CleanCap Reagent AG(3'OMe), 10 umole | 10 umol |
TriLink | N-7413-100 | CleanCap Reagent AG(3'OMe), 100 umole | 100 umol |
文献引用;
● Rothgangl, T;Dennis, MK;Lin, PJC;Oka, R;Witzigmann, D;Villiger, L;Qi, W;Hruzova, M;Kissling, L;Lenggenhager, D;Borrelli, C;Egli, S;Frey, N;Bakker, N;Walker, JA;Kadina, AP;Victorov, DV;Pacesa, M;Kreutzer, S;Kontarakis, Z;Moor, A;Jinek, M;Weissman, D;Stoffel, M;van Boxtel, R;Holden, K;Pardi, N;Th . In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
● Weissman, D;Alameh, MG;de Silva, T;Collini, P;Hornsby, H;Brown, R;LaBranche, CC;Edwards, RJ;Sutherland, L;Santra, S;Mansouri, K;Gobeil, S;McDanal, C;Pardi, N;Hengartner, N;Lin, PJC;Tam, Y;Shaw, PA;Lewis, MG;Boesler, C;?ahin, U;Acharya, P;Haynes, BF;Korber, B;Montefiori, DC; . D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
● Pandey, RR;Delfino, E;Homolka, D;Roithova, A;Chen, KM;Li, L;Franco, G;V . The Mammalian Cap-Specific m6Am RNA Met-hyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues
● Mu, Z;Wiehe, K;Saunders, KO;Henderson, R;Cain, DW;Parks, R;Martik, D;Mansouri, K;Edwards, RJ;Newman, A;Lu, X;Xia, SM;Bonsignori, M;Montefiori, D;Han, Q;Venkatayogi, S;Evangelous, T;Wang, Y;Rountree, W;Tam, Y;Barbosa, C;Munir Alam, S;Williams, WB;Pardi, N;Weissman, D;Haynes, BF; . Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles
● Martinez, DR;Schaefer, A;Leist, SR;De la Cruz, G;West, A;Atochina-Vasserman, EN;Parks, R;Barr, M;Li, D;Yount, B;Saunders, KO;Weissman, D;Haynes, BF;Montgomery, SA;Baric, RS; . Chimeric spike mRNA vaccines protect against sarbecovirus challenge in mice
TriLink BioTechnologies公司1996年成立于美国加州圣地亚哥,是世界著名的核酸修饰技术领域的研究者。TriLink致力于高品质核酸修饰产品的研发和生产,可为科研、诊断、OEM和医疗机构提供包括核苷酸、常规及特殊修饰的寡核苷酸产品,可广泛应用于基因治疗,核苷类化疗,寡核苷酸治疗和诊断领域。此外,TriLink还可提供定制、合同研究服务和ISO/ QSR标准的cGMP生产设施。TriLink完善的产品及研发服务解决方案有助于推动药物发现和生物医学研究。
更多详情请联系TriLink中国独家代理商——欣博盛生物
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
● Rothgangl, T;Dennis, MK;Lin, PJC;Oka, R;Witzigmann, D;Villiger, L;Qi, W;Hruzova, M;Kissling, L;Lenggenhager, D;Borrelli, C;Egli, S;Frey, N;Bakker, N;Walker, JA;Kadina, AP;Victorov, DV;Pacesa, M;Kreutzer, S;Kontarakis, Z;Moor, A;Jinek, M;Weissman, D;Stoffel, M;van Boxtel, R;Holden, K;Pardi, N;Th . In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
● Weissman, D;Alameh, MG;de Silva, T;Collini, P;Hornsby, H;Brown, R;LaBranche, CC;Edwards, RJ;Sutherland, L;Santra, S;Mansouri, K;Gobeil, S;McDanal, C;Pardi, N;Hengartner, N;Lin, PJC;Tam, Y;Shaw, PA;Lewis, MG;Boesler, C;?ahin, U;Acharya, P;Haynes, BF;Korber, B;Montefiori, DC; . D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
● Pandey, RR;Delfino, E;Homolka, D;Roithova, A;Chen, KM;Li, L;Franco, G;V . The Mammalian Cap-Specific m6Am RNA Met-hyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues
● Mu, Z;Wiehe, K;Saunders, KO;Henderson, R;Cain, DW;Parks, R;Martik, D;Mansouri, K;Edwards, RJ;Newman, A;Lu, X;Xia, SM;Bonsignori, M;Montefiori, D;Han, Q;Venkatayogi, S;Evangelous, T;Wang, Y;Rountree, W;Tam, Y;Barbosa, C;Munir Alam, S;Williams, WB;Pardi, N;Weissman, D;Haynes, BF; . Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles
● Martinez, DR;Schaefer, A;Leist, SR;De la Cruz, G;West, A;Atochina-Vasserman, EN;Parks, R;Barr, M;Li, D;Yount, B;Saunders, KO;Weissman, D;Haynes, BF;Montgomery, SA;Baric, RS; . Chimeric spike mRNA vaccines protect against sarbecovirus challenge in mice